Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium
Journal of Labelled Compounds and Radiopharmaceuticals · 2023
DOI: 10.1002/jlcr.4022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2023. Verfasst von Bachir Latli und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Radiosynthesis Laboratory, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
The generation of amyloid beta peptides that aggregate in the brain is believed to play a major role in Alzheimer's disease. In theory, the inhibition of beta‐site amyloid precursor protein‐cleaving enzyme 1 (BACE1), which catalyzes the initial rate‐limiting step in amyloid beta production, may slow or stop Alzheimer's disease. Herein, we report the preparation of two potent BACE1 inhibitors, BI 1147560 ( 1 ) and BI 1181181 ( 2 ), labeled with carbon‐14 and with deuterium. The use of advanced key chiral intermediates like 3 and 5 shortened the carbon‐14 syntheses of these two compounds to five and six steps, respectively, and helped in preparing them with very high chemical purity and enantiomeric excess without deviating from the process chemistry route. For the deuterium synthesis, oxetan‐3‐ylmethanamine [ 2 H 6 ]‐7 and 2‐fluoro‐2‐methylpropan‐1‐amine [ 2 H 6 ]‐9 were prepared then used with the chiral intermediate 5 to furnish deuterium labeled 1 and 2 , respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Radiosynthesis Laboratory, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
ORCID-Profile: Bachir Latli
Zitieren
APA
Latli, B., Hrapchak, M. J., Reeves, J. T., Lee, H., & Song, J. J. (2023). Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.4022
Vancouver
Latli B, Hrapchak MJ, Reeves JT, Lee H, Song JJ. Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium. Journal of Labelled Compounds and Radiopharmaceuticals. 2023. doi:10.1002/jlcr.4022
BibTeX
@article{Latli2023,
author = {Latli, Bachir and Hrapchak, Matt J and Reeves, Jonathan T and Lee, Heewon and Song, Jinhua J},
title = {Synthesis of beta‐site amyloid precursor protein‐cleaving enzyme 1 inhibitors BI 1147560 and BI 1181181 labeled with carbon‐14 and deuterium},
journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
year = {2023},
doi = {10.1002/jlcr.4022}
}
EUVIMED